Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Biden Signing Wide-Range Executive Order on Artificial Intelligence
President Joe Biden on Monday will sign a sweeping executive order to guide the development of artificial intelligence — requiring industry to develop safety and security standards, introducing new consumer protections and giving federal agencies an extensive to-do list to oversee the rapidly progressing technology.
Be Well: Allure Magazine's Top Beauty Products
Beauty tips from Allure Magazine.
Study: The 10 Best States for Millennials
A new study finds where millennials live can affect how well they can do.
Apple Holding Keynote Event Monday Night
Apple's latest keynote event will be live-streamed on its website, YouTube and Apple TV At 8 p.m ET.
McDonald's Reports Better-Than-Expected Third-Quarter Results
McDonald's reported better-than-expected profit and sales in the third quarter.
Pres. Biden Signs Executive Order on Artificial Intelligence
President Joe Biden signed a wide-ranging executive order on artificial intelligence in the U.S.
Stocks Jump After Mergers, Earnings and Ahead of Economic Data, Fed Decision
Stocks jumped in Monday's early session after a slew of earnings and other news events that saw the market attempt to make a positive finish to a rough month. Investors also braced for a rate decision from the Federal Reserve as well as the latest jobs report this week.
Candy Inflation Hits Double Digits for the Second Halloween in a Row
Cocoa prices are trading at 44-year highs and global sugar prices are at 12-year highs.
Big Business This Week: Auto Strike Breakthrough, Robotaxis Stalled and More
Big Business This Week is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
